Kenya's pharmaceutical manufacturing sector, regulated by the Pharmacy and Poisons Board (PPB), imports the majority of its Furosemide API requirements from Indian and international manufacturers. For Kenyan finished-dose manufacturers producing furosemide 40 mg tablets, injectable formulations, or combination cardiovascular products, the API sourcing decision determines regulatory registration timelines, batch release consistency, and market pricing competitiveness. This guide profiles the top 10 furosemide API bulk manufacturer companies serving Kenya, with GMP certification standing, export track record, and documentation depth relevant to PPB registration.
The Kenyan market requires WHO-GMP certification as the baseline standard for Furosemide API supplier qualification, with PPB plant registration required for the API manufacturer to be listed as a permitted source in a Kenyan registered finished-dose product. All ten manufacturers profiled below meet the baseline GMP certification requirement. The differentiation lies in documentation depth, response times, export logistics infrastructure for the Mombasa port corridor, and technical support for Kenyan formulation partners.
Quick Comparison: Top 10 Furosemide API Manufacturers for Kenya
| # | Manufacturer | Location | Key Strength for Kenya |
| 1 | Kodel Life | Morbi, Gujarat, India | ISO 9001:2015, FDA-compliant, 21-country export, direct Kenya documentation support |
| 2 | Aarti Drugs Ltd | Tarapur / Mumbai, India | Large-scale API producer, established East Africa export routes |
| 3 | Sri Krishna Pharma (SKPL) | Hyderabad, India | USFDA + EU GMP approved, exports to 75+ countries |
| 4 | Salvavidas Pharmaceutical | Surat, Gujarat, India | WHO-GMP, active in African markets |
| 5 | Amsal Chem Pvt Ltd | Ahmedabad, India | Established Furosemide API producer with pharmacopoeial documentation |
| 6 | Aurobindo Pharma Ltd | Hyderabad, India | Large integrated pharma with global API division |
| 7 | Cipla Ltd | Mumbai, India | Long-standing African market presence, including Kenya |
| 8 | Sun Pharmaceutical Industries | Mumbai / Vadodara, India | Global API leader with strong African export footprint |
| 9 | Dr. Reddy's Laboratories | Hyderabad, India | API division serving global cardiovascular generic markets |
| 10 | Jai Radhe Sales | Ahmedabad, India | Established API distributor and exporter for African markets |
Kodel Life - Direct Furosemide API Supply to Kenya
Kodel Life manufactures Furosemide API at its Morbi, Gujarat facility under ISO 9001:2015 Quality Management System certification and FDA-compliant cGMP manufacturing practices. The facility exports to 21 countries across 5 continents, with active export lanes into East Africa including Kenya, Tanzania, and Ethiopia. For Kenyan pharmaceutical buyers, Kodel Life provides direct-to-manufacturer documentation support tailored to PPB registration requirements: WHO-GMP certificate, batch-specific COAs to IP/BP/USP grades, GHS-compliant MSDS, Certificate of Country of Origin, and CDSCO plant registration documentation for the Kenyan importer's PPB submission.
The technical team responds to Kenyan buyer enquiries within one to two business days, with COA, DMF reference letter, and stability data summaries available on request. Shipping to Kenya is routed through Mombasa port with typical transit times of 21 to 28 days from Mundra or Nhava Sheva. Contact info@kodellife.com or call +91 75023 33335.
Aarti Drugs Ltd - Scale and East Africa Export Track Record
Aarti Drugs, part of the Aarti Group of Industries established in 1984, is one of India's larger public listed API manufacturers with a broad portfolio spanning cardiovascular, anti-inflammatory, and anti-infective molecules. The company operates multiple API manufacturing facilities in Tarapur and Sarigam (Maharashtra and Gujarat) and has an established export presence in African markets including Kenya. For high-volume Kenyan buyers, Aarti Drugs offers commercial-scale batch availability and established regulatory documentation infrastructure.
Sri Krishna Pharma (SKPL) - Multi-Authority GMP Approvals
Sri Krishna Pharma, headquartered in Hyderabad, is a well-established Indian API manufacturer with Furosemide/Frusemide in its portfolio and CEP documentation for European market supply. The company's API facilities carry USFDA, TGA, and EU health authority GMP approvals, with exports to over 75 countries including African destinations. For Kenyan buyers whose finished-dose products may target EU or Southern African Development Community (SADC) markets in addition to Kenya, SKPL's multi-authority regulatory standing simplifies dossier support across multiple markets from a single supplier.
For a full understanding of what GMP certification depth and multi-authority approvals mean for a Furosemide API sourcing decision, the complete guide to Furosemide API manufacturing and global supply covers the regulatory certification framework and how it applies to buyer supplier evaluation exercises.
Salvavidas Pharmaceutical Pvt Ltd - Growing African Market Presence
Salvavidas Pharmaceutical, based in Surat, Gujarat, is a WHO-GMP certified API manufacturer with a wide portfolio across cardiovascular, oncology, neurology, and anti-infective therapeutic areas. The company reports active export operations across Asia, Africa, and Europe, positioning it as an accessible option for Kenyan buyers seeking Indian API supply with baseline WHO-GMP documentation depth suitable for PPB registration.
Amsal Chem Pvt Ltd - Established Furosemide Producer
Amsal Chem, based in Ahmedabad, Gujarat, is listed among established Indian Furosemide API manufacturers on international pharmaceutical directories including PharmaCompass. The company supplies to global pharmaceutical buyers with pharmacopoeial-grade Furosemide API documentation. Kenyan buyers evaluating Amsal Chem should confirm current GMP certification scope, pharmacopoeial grade availability (IP/BP/USP/EP), and East Africa export documentation experience during pre-qualification.
Kenyan procurement teams initiating a new Indian Furosemide API supplier qualification should apply a structured evaluation framework covering GMP certification, COA quality, and documentation completeness. The Furosemide API supplier evaluation guide sets out a step-by-step evaluation approach that Kenyan buyers can apply directly to any prospective Indian manufacturer, including all ten on this list.
Aurobindo Pharma Ltd - Integrated Pharmaceutical Group
Aurobindo Pharma, headquartered in HITEC City, Hyderabad, is one of India's largest integrated pharmaceutical manufacturers with a substantial API division producing cardiovascular, antibiotic, antiretroviral, and CNS APIs. The company's African market presence is well-established, and its scale supports high-volume commercial orders for Kenyan finished-dose manufacturers with recurring annual demand. Aurobindo's regulatory documentation depth reflects its multi-authority certification portfolio.
Cipla Ltd - Long-Standing African Market Presence
Cipla, founded in 1935 and headquartered in Mumbai, is one of India's most globally recognised pharmaceutical companies, particularly known for its long-standing commitment to African healthcare markets including HIV/AIDS antiretroviral supply. The company operates both finished-dose and API divisions, with African subsidiaries including South African operations. For Kenyan buyers, Cipla's brand recognition and established African market infrastructure make it a familiar option, though smaller finished-dose manufacturers should confirm minimum order quantity requirements against their consumption profile.
Sun Pharmaceutical Industries Ltd - Global API Scale
Sun Pharma, established in 1983 and headquartered in Mumbai, is India's largest pharmaceutical company by market capitalisation and operates a substantial API manufacturing division across multiple Indian facilities. The company's export footprint includes African markets, and its integrated pharmaceutical infrastructure supports commercial-scale API supply with the regulatory documentation depth required for regulated and semi-regulated market registrations.
Kenyan buyers importing Furosemide API from Indian manufacturers should also understand the export documentation and customs framework operating at the Indian origin end of the shipment. The Furosemide API export from India guide covers ITCHS coding, shipping bill preparation, COO issuance, and the market-specific documentation packs required for African destinations including Kenya.
Dr. Reddy's Laboratories - Established Global API Division
Dr. Reddy's Laboratories, headquartered in Hyderabad, is one of India's most internationally established pharmaceutical companies with a substantial API division supplying global generic drug manufacturers. The company's cardiovascular API portfolio has served international markets for over three decades. For Kenyan buyers, Dr. Reddy's offers scale, regulatory documentation depth, and established African market infrastructure through its formulation and distribution operations across Sub-Saharan Africa.
Jai Radhe Sales - Established API Distributor
Jai Radhe Sales, founded in 1999 and based in Ahmedabad, is an established global distributor specialising in Indian-origin pharmaceutical ingredients. The company acts as a sourcing partner for buyers who want a single interface for multiple API requirements from qualified Indian manufacturers, with technical and regulatory support services included. For Kenyan buyers with a diverse API portfolio and preference for a single-supplier relationship covering multiple molecules, distributor models such as Jai Radhe Sales provide an alternative to direct manufacturer relationships.
What Kenyan Pharmaceutical Buyers Should Verify Before Placing a First Order
Regardless of which of the ten manufacturers above your team evaluates first, five verification steps apply universally to any Furosemide API import into Kenya. The Kenyan Pharmacy and Poisons Board requires that the API manufacturer be registered as an approved source for the specific finished-dose product in which the API is used. Registration timelines vary from six to twelve months for a new API source qualification. Before initiating the registration process, confirm five documents from the prospective supplier.
First, request a current WHO-GMP certificate from CDSCO with the Furosemide API manufacturing line named in the scope and an inspection date within the last three years. Second, request a batch-specific COA to the required pharmacopoeial grade (IP, BP, or USP depending on the finished-dose product registration) with numeric assay result and named related substances. Third, request a Certificate of Country of Origin from a recognised Indian chamber of commerce for the specific consignment. Fourth, request a GHS-compliant Material Safety Data Sheet with CAS 54-31-9 identification and English-language hazard classifications. Fifth, request a sample export documentation pack matching the pack that will accompany the first commercial shipment through Mombasa port.
A more comprehensive procurement checklist covering all documentation and quality parameters that Kenyan buyers should verify before qualifying any Indian Furosemide API bulk manufacturer is available in the Furosemide API bulk manufacturer India checklist.
Start With the Supplier Who Answers Your Questions First
Ten manufacturers, one decision. The differentiating factor across a shortlist of qualified Indian Furosemide API suppliers is rarely the pharmacopoeial specification (all qualified manufacturers meet USP or BP) or the base price (competitive across the shortlist). It is the responsiveness of the technical team, the completeness of the pre-qualification documentation, and the willingness to provide direct market-specific documentation support for Kenyan PPB registration.
Kodel Life responds to Kenyan buyer enquiries within one to two business days with a complete pre-qualification documentation pack including WHO-GMP certificate, batch-specific COA, ICH Q3A impurity profile, stability data summary, and Kenya-market export documentation package. Contact info@kodellife.com or call +91 75023 33335 to request the Kenya-specific export quote.
Request Kenya Export Quote: Contact Kodel Life for Kenya-specific Furosemide API pricing, PPB documentation support, and Mombasa port shipping options. Email info@kodellife.com or call +91 75023 33335. Response within one to two business days.
